Hepatitis Monthly

Published by: Kowsar

Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis

Mostafa Salehi-Vaziri 1 , Farzin Sadeghi 2 , Amir Almasi Hashiani 3 , Mohammad Gholami Fesharaki 4 and Seyed Moayed Alavian 5 , *
Authors Information
1 Department of Arboviruses and Viral Hemorrhagic Fevers, Pasteur Institute of Iran, Tehran, IR Iran
2 Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, IR Iran
3 Medical Ethics and Law Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
5 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences Tehran, IR Iran
Article information
  • Hepatitis Monthly: April 01, 2016, 16 (4); e35577
  • Published Online: April 26, 2016
  • Article Type: Review Article
  • Received: December 17, 2015
  • Revised: February 2, 2016
  • Accepted: February 7, 2016
  • DOI: 10.5812/hepatmon.35577

To Cite: Salehi-Vaziri M, Sadeghi F, Almasi Hashiani A, Gholami Fesharaki M, Alavian S M. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis, Hepat Mon. 2016 ; 16(4):e35577. doi: 10.5812/hepatmon.35577.

Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Objectives
3. Methods
4. Results
5. Discussion
6. Conclusion
  • 1. Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014; 384(9959): 2053-63[DOI][PubMed]
  • 2. Chen DS. Toward elimination and eradication of hepatitis B. J Gastroenterol Hepatol. 2010; 25(1): 19-25[DOI][PubMed]
  • 3. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012; 30(12): 2212-9[DOI][PubMed]
  • 4. Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris). 2010; 58(4): 258-66[DOI][PubMed]
  • 5. Chang ML, Liaw YF. Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management. J Hepatol. 2014; 61(6): 1407-17[DOI][PubMed]
  • 6. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2095-128[DOI][PubMed]
  • 7. Andre F. Hepatitis B epidemiology in Asia, the middle East and Africa. Vaccine. 2000; 18-2[DOI]
  • 8. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006; 28: 112-25[DOI][PubMed]
  • 9. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015; 386(10003): 1546-55[DOI]
  • 10. Zali MR. Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J. 1996; 2(2): 290-8
  • 11. Zali MR, Mohammad K, Noorbala AA, Noorimayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J. 2005; 11(1-2): 62-7[PubMed]
  • 12. Alizadeh AH, Ranjbar M, Ansari S, MirArab A, Alavian SM, Mohammad K, et al. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr Health J. 2006; 12(5): 528-37[PubMed]
  • 13. Farhat A, Khademi G, Mazlouman SJ. The prevalence of hepatitis B carrier state in Khorassan province of Iran. Saudi Med J. 2003; 24(5): 549-51[PubMed]
  • 14. Gholamreza R, Shahryar S, Abbasali K, Hamidreza J, Abdolvahab M, Khodaberdi K, et al. Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population. Indian J Med Sci. 2007; 61(5): 263-8[PubMed]
  • 15. You CR, Lee SW, Jang JW, Yoon SK. Update on hepatitis B virus infection. World J Gastroenterol. 2014; 20(37): 13293-305[DOI][PubMed]
  • 16. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus infection in Iran: A systematic review. Hepat Mon. 2008; 8(4): 281-94
  • 17. Poorolajal J, Majdzadeh R. Prevalence of chronic hepatitis B infection in Iran: a review article. J Res Med Sci. 2009; 14(4): 249-58[PubMed]
  • 18. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4): 264-9
  • 19. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007; 4(10)[DOI][PubMed]
  • 20. Harris R, Bradburn M, Deeks J, Harbord R, Altman D, Sterne J. Metan: fixed-and random-effects meta-analysis. Stata J. 2008; 8(1): 3
  • 21. Harbord RM, Harris RJ, Sterne JA. Updated tests for small-study effects in meta-analyses. Stata J. 2009; 9(2): 197
  • 22. Sterne J. A. , Harbord R. M. . Funnel plots in meta-analysis. Stata J. 2004; (4): 127-41
  • 23. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009; 12(3): 225-31[PubMed]
  • 24. Pourshams A, Nasiri J, Mohammadkhani A, Nasrollahzadeh D. Hepatitis B in Gonbad-Kavoos: prevalence, risk factors and intrafamilial spreading. Govaresh. 2004; 9(4): 222-5
  • 25. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg. 1993; 96(5): 277-87[PubMed]
  • 26. Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepat Mon. 2011; 11(5): 346-50[PubMed]
  • 27. Shakeri MT, Foghanian B, Nomani H, Ghayour-Mobarhan M, Nabavinia MS, Rostami S, et al. The prevalence of hepatitis B virus infection in mashhad, iran: a population-based study. Iran Red Crescent Med J. 2013; 15(3): 245-8[DOI][PubMed]
  • 28. Shahramian E, Moradi A,, Moin AA, noori NM, Solimani G. Hepatitis B sero-markers evaluation in People born. Yafteh. 2009; 10(4): 107-14
  • 29. Salehi M, Alavian SM, Tabatabaei SV, Izadi S, Sanei Moghaddam E, Amini Kafi-Abad S, et al. Seroepidemiology of HBV infection in South-East of iran; a population based study. Iran Red Crescent Med J. 2012; 14(5): 283-8[PubMed]
  • 30. Moezzi M, Imani R, Khosravi N, Pourheidar B, Ganji F, Karimi A. Hepatitis B seroprevalence and risk factors in adult population of chaharmahal and bakhtiari province in 2013. Hepat Mon. 2014; 14(5)[DOI][PubMed]
  • 31. Bayat-Makou J, Shahnazi A, Koushavar H. Prevalent infections in north-west region of Tabriz. Med J Tabriz Uni Med Sci. 2003; 59: 30
  • 32. Nokhodian Z, Kassaian N, Ataei B, Javadi AA, Shoaei P, Farajzadegan Z, et al. Hepatitis B markers in Isfahan, Central Iran: a population-based study. Hepat Mon. 2009; 9(1): 12-6
  • 33. Alavian SM, Tabatabaei SV, Nourizad S, Mansouri F, Khademi N, Kafi-abad SA, et al. Seroepidemiology of HBV Infection in Kermanshah-West of Iran; a Population Based Study. Jundishapur J Microbio. 2012; 5(4): 564-9[DOI]
  • 34. Alavian SM, Tabatabaei SV, Ghadimi T, Beedrapour F, Kafi-Abad SA, Gharehbaghian A, et al. Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study. Int J Prev Med. 2012; 3(11): 770-5[PubMed]
  • 35. Keyvani H, Sohrabi M, Zamani F, Poustchi H, Ashrafi H, Saeedian F, et al. A population based study on hepatitis B virus in northern iran, amol. Hepat Mon. 2014; 14(8)[DOI][PubMed]
  • 36. Ghadir MR, Belbasi M, Heidari A, Jandagh M, Ahmadi I, Habibinejad H, et al. Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran. Hepat Mon. 2012; 12(2): 112-7[DOI][PubMed]
  • 37. Abedi F, Madani H, Asadi A, Nejatizadeh A. Significance of blood-related high-risk behaviors and horizontal transmission of hepatitis B virus in Iran. Arch Virol. 2011; 156(4): 629-35[DOI][PubMed]
  • 38. Alavian SM. Hepatitis B virus infection in Iran; Changing the epidemiology. Arch Clin Infec Dis. 2010; 5(1): 51-61
  • 39. Adibi P, Ghassemian R, Alavian SM, Ranjbar M, Mohammadalizadeh AH, Nematizadeh F, et al. Effectiveness of hepatitis B vaccination in children of chronic hepatitis B mothers. Saudi Med J. 2004; 25(10): 1414-8[PubMed]
  • 40. Kabir A, Alavian SM, Ahanchi N, Malekzadeh R. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. Hepatol Res. 2006; 36(4): 265-71[DOI][PubMed]
  • 41. Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A. Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine. 2010; 28(3): 623-31[DOI][PubMed]
  • 42. Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Ghalichi L, et al. Seroprotection of hepatitis B vaccine and need for booster dose: a meta-analysis. Hepat Mon. 2009; 9(4): 293-304
  • 43. Poorolajal J, Mahmoodi M, Haghdoost A, Majdzadeh R, Nasseri-Moghaddam S, Ghalichi L, et al. Booster dose vaccination for preventing hepatitis B. Cochrane Database Syst Rev. 2010; (11)[DOI][PubMed]
  • 44. Al Ghamdi SS, Fallatah HI, Fetyani DM, Al-Mughales JA, Gelaidan AT. Long-term efficacy of the hepatitis B vaccine in a high-risk group. J Med Virol. 2013; 85(9): 1518-22[DOI][PubMed]
  • 45. Elrashidy H, Elbahrawy A, El-Didamony G, Mostafa M, George NM, Elwassief A, et al. Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents. Hum Vaccin Immunother. 2013; 9(9): 2002-6[DOI][PubMed]
  • 46. Masuet-Aumatell C, Ramon-Torrell JM, Casanova-Rituerto A, Banque-Navarro M, Davalos-Gamboa Mdel R, Rodriguez SL. Seroprevalence of hepatitis B in two period birth cohorts of Bolivian children: effect of universal vaccination. Trans R Soc Trop Med Hyg. 2013; 107(9): 578-83[DOI][PubMed]
  • 47. Mizusawa M, Perlman DC, Lucido D, Salomon N. Rapid loss of vaccine-acquired hepatitis B surface antibody after three doses of hepatitis B vaccination in HIV-infected persons. Int J STD AIDS. 2014; 25(3): 201-6[DOI][PubMed]
  • 48. Nisihara R, De Bem RS, Negreiros PH, Utiyama SR, Oliveira NP, Amarante H. Low hepatitis B vaccine response in children with Down syndrome from Brazil. Child Care Health Dev. 2014; 40(4): 607-9[DOI][PubMed]
  • 49. Rezaee-Zavareh MS, Einollahi B. Hepatitis B vaccination: needs a revision. Hepat Mon. 2014; 14(3)[DOI][PubMed]
  • 50. Said ZN. An overview of occult hepatitis B virus infection. World J Gastroenterol. 2011; 17(15): 1927-38[DOI][PubMed]
  • 51. Anvari FA, Alavian SM, Norouzi M, Mahabadi M, Jazayeri SM. Prevalence and molecular analysis of occult hepatitis B virus infection isolated in a sample of cryptogenic cirrhosis patients in iran. Oman Med J. 2014; 29(2): 92-6[DOI][PubMed]
  • 52. Keyvani H, Agah S, Kabir A, Alavian SM. Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study. Ann Hepatol. 2013; 12(2): 213-9[PubMed]
  • 53. Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology. 2004; 126(1): 102-10[PubMed]
  • 54. Raimondo G, Pollicino T, Romano L, Zanetti AR. A 2010 update on occult hepatitis B infection. Pathol Biol (Paris). 2010; 58(4): 254-7[DOI][PubMed]
  • 55. Candotti D, Allain JP. Transfusion-transmitted hepatitis B virus infection. J Hepatol. 2009; 51(4): 798-809[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments